PMTCT: Addressing low uptake of ARV drugs
14 January 2014
Provision of antiretroviral (ARV) drugs to HIV infected mothers and their newborn babies is a critical component of prevention of mother-to-child transmission (PMTCT) of HIV, and is key to changing the trajectory of the HIV epidemic in sub-Saharan Africa.
But uptake of ARV drugs for PMTCT remains unacceptably low in many countries across sub-Saharan Africa.
This new brief has analysed the evidence available to assess what the barriers are, and makes recommendations of how to address them.